FDA Inspection 985577 — Hanlim Pharm Co. Ltd.

Hanlim Pharm Co. Ltd. — FEI 3004886113

The FDA completed an inspection of Hanlim Pharm Co. Ltd. on Jul 19, 2016 in Yongin. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 19, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Yongin (Korea (the Republic of))

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.